Healthcare · Diagnostics & Research
· website
· 27 employees
$1.15
52wk 0.84 – 1.40
Overall
57.0
Value
35.5
Growth
62.1
Health
54.3
Quality
88.6
Momentum
50.7
Dividend
—
Price
About Cryosite Limited
Cryosite Limited provides outsourced clinical trials logistic services in Australia. It operates through Ambient, cold, and frozen; Ultra-frozen and cryogenic; and Cord Blood segments. The Ambient, cold, and frozen segment provides good manufacturing practice (GMP) clinical trial materials, scheduled medicines, controlled drug storage, clinical ancillary supplies, medical devices, and commercial products with strict temperature requirements. The Ultra-frozen and cryogenic segment offers advanced therapy medicinal products (ATMPS), such as cell and gene therapies (CGT), cell therapies, mRNA-based medicines, biological samples, and research and development materials requiring high-integrity cold storage. The Cord Blood segment provides storage of cord blood cell and tissue samples for personal or directed therapeutic use by maintaining under validated chain-of-identity controls. It also offers reverse logistics services, secondary packaging, inventory management, and quality transportation and distribution solutions. Cryosite Limited was incorporated in 1999 and is based in South Granville, Australia.
Price analytics
Returns
1 day
0.0%
1 week
-2.5%
1 month
-8.0%
3 months
-8.0%
6 months
5.5%
1 year
33.7%
3 years
76.9%
Risk
Volatility (1y ann.)
42.6%
Beta vs ASX 200
0.47
Sharpe (1y)
0.80
VaR 95% (1-day)
-2.8%
Max drawdown (1y)
-23.1%
Off 1-year high
-11.5%
Technicals
RSI(14)
20
OS
vs 50DMA
-5.0%
vs 200DMA
1.0%
Trend
Golden cross
Fundamental trends
Financial statements
Loading…
Scoring breakdown
(2 Oct 2026)
Value35.5
Trailing P/E
35
Forward P/E
—
PEG ratio
59
EV / EBITDA
17
Price / Book
0
Price / Sales
72
Growth62.1
Revenue growth (1y)
81
Revenue CAGR (3y)
67
EPS growth (1y)
40
EPS CAGR (3y)
59
Financial Health54.3
Net debt / EBITDA
68
Interest coverage (EBIT/interest)
100
Current ratio
31
Debt / Equity
23
Quality (Profitability & Cash Flow)88.6
Return on equity
100
Return on assets
87
Operating margin
75
Net margin
89
Cash conversion (OCF / net income)
—
Dividend / Income—
No meaningful dividend — pillar excluded from the overall score.
Momentum50.7
6-month return vs ASX 200
63
Price vs 200-day average
53
Price vs 50-day average
25
Position in 52-week range
55
Hover a row's info icon for the exact rule. Bounds and weights are configurable in
the Django admin (Scoring configuration).